CMA Defends £260M Drug Fine For Overcharging NHS
The U.K.'s competition watchdog began its defense on Tuesday of fines totaling more than £260 million ($309 million) against pharmaceutical companies accused of overcharging the National Health Service for hydrocortisone tablets...To view the full article, register now.
Already a subscriber? Click here to view full article